Clinical Trials Logo

Filter by:
NCT ID: NCT00383214 Terminated - Clinical trials for Systemic Lupus Erythematosus

Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Start date: May 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Epratuzumab with standard treatments for patients with SLE.

NCT ID: NCT00383188 Completed - Clinical trials for Arthritis, Rheumatoid

An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

Start date: December 15, 2006
Phase: Phase 2
Study type: Interventional

Investigating the safety and tolerability of a p38 inhibitor as monotherapy in subjects who have failed at least 1 DMARD.

NCT ID: NCT00382837 Withdrawn - Clinical trials for Systemic Lupus Erythematosus

Study of Epratuzumab in Systemic Lupus Erythematosus

Start date: January 2007
Phase: Phase 3
Study type: Interventional

Epratuzumab is an investigational antibody designed to help treat SLE. The purpose is to evaluate safety and long term efficacy in concert with standard SLE treatments

NCT ID: NCT00382278 Terminated - Liver Cirrhosis Clinical Trials

Safety Study of Autologous Stem Cell in Liver Cirrhosis

Start date: November 2005
Phase: Phase 1/Phase 2
Study type: Interventional

It is a fase I/II clinical study to evaluate feasibility, safety and kinetics of cellular therapy with bone marrow-derived mononuclear cells (ABMMC) in patients with liver cirrhosis. All the patients have moderate liver disfunction and a waiting time expectancy of liver transplantation longer than 12 months due their low MELD score. The ABMMC are labeled with 99mTc and infused through the hepatic artery. Scintigraphy is performed 2 and 24 hours after infusion. Patients are submitted to frequent clinical, laboratorial and image evaluation during the follow up period of 12 months.

NCT ID: NCT00382031 Completed - Clinical trials for Head and Neck Cancer

Zalutumumab in Patients With Non-curable Head and Neck Cancer

Start date: November 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate if zalutumumab in combination with Best Supportive Care (BSC) is superior to BSC in non-curable patients with head and neck cancer

NCT ID: NCT00380991 Completed - Hygiene Clinical Trials

Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the absence of potential irritation (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Delicata (new fragrance of Dermacyd)

NCT ID: NCT00379496 Completed - Fibromyalgia Clinical Trials

Trial of Acupuncture Added to Usual Treatment for Fibromyalgia

Start date: April 2000
Phase: Phase 0
Study type: Interventional

The aim of this study was to evaluate the effect of acupuncture as a treatment for this condition. Fifty-eight women diagnosed with fibromyalgia were randomly allocated to two groups. One group received acupuncture (n=34) twice a week for 20 sessions in addition to tricyclic antidepressants and exercises. The control group (n=24) received only tricyclic antidepressants and exercises. A blinded assessor evaluated patients’ pain using visual analog scale (VAS), tender points number (TePsN) and myalgic index (MI). The same assessor also evaluated quality of life (QoL) using SF-36. These evaluations were done prior to treatments, at the end of the 20 sessions, and again at six months, one year and two years after the first evaluation. At the end of the 20 sessions, patients who had received acupuncture were significantly better than those who had not in all measures of pain (VAS, TePsN, MI) and in five subscales of SF-36. After six months, the acupuncture group was significantly better than the control group in some measures of pain (TePsN and MI) and in three subscales of SF-36. After one year, the acupuncture group showed significant advantage in only one subscale of SF-36; at two years there were no significant differences between the two groups on all outcome measures. The addition of acupuncture to usual treatment for fibromyalgia is beneficial for pain and quality of life, but only in first six months.

NCT ID: NCT00378495 Terminated - Kala Azar Clinical Trials

Miltefosine for Brazilian Visceral Leishmaniasis

Start date: April 2005
Phase: Phase 1/Phase 2
Study type: Interventional

Miltefosine will be administered to Brazilian patients with kala azar

NCT ID: NCT00377637 Completed - Lupus Nephritis Clinical Trials

A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Start date: July 2005
Phase: Phase 3
Study type: Interventional

This 2 arm study assessed the efficacy of Mycophenolate Mofetil (MMF; CellCept) compared to cyclophosphamide in inducing a response in patients with lupus nephritis, and the long term efficacy of MMF compared to azathioprine in maintaining remission and renal function. Patients were randomized to receive either MMF (1.5 g twice daily [bid]) or cyclophosphamide (0.5-1.0 g/m^2 in monthly pulses) in the induction phase. Those patients meeting criteria for response were re-randomized for entry into the maintenance phase, to receive either MMF (1 g bid) or azathioprine (2 mg/kg/day).

NCT ID: NCT00376493 Terminated - Septic Abortion Clinical Trials

Prolonged Treatment for Infected Abortion After Hospital Discharge.

APA
Start date: May 2006
Phase: Phase 4
Study type: Interventional

Patients with infected abortion will be treated with dilatation and curettage, intravenous antibiotics. The purpose of this study is to verify if it is necessary to keep the use of oral antibiotics after hospital discharge.